Alexis Kramer

The FDA has approved Moderna’s next-generation Covid-19 vaccine, but said that people aged 12 to 64 should only get the shot if they have a health condition that puts them at risk from the virus. @maxonwifi https://t.co/QfSPbI1uHZ

RT @ByLizC: Summit says PD-1xVEGF bispecific ivonsecimab misses overall survival in closely-watched lung cancer study $SMMT https://t.co/…

The US Supreme Court will continue deciding whether to take up a pivotal case on state PBM regulation after the federal government offered its stance on the issue. @Nicole_DeFeudis https://t.co/061Y3aTSvN

RT @ZacharyBrennan: One of those rare cases (for an ultra rare disease drug) where the FDA adcomm votes in favor (10-6) and FDA still rejec…

RT @endpts: 🧬Meet the Illumina-ti: The DNA giant's alumni have founded more than 70 companies and raised $5.2 billion in VC. Some are custo…

RT @endpts: A court has blocked the Trump administration's plan to reorganize HHS and 20+ federal agencies, calling it an “unconstitutional…

RT @maxonwifi: The "MAHA Report" is here. Here are four takeaways for the drug industry: https://t.co/WZ852SpqIw

RT @maxonwifi: Breaking: @DrMakaryFDA and @VPrasadMDMPH spell out new FDA framework for future Covid vaccine approvals in @NEJM editorial.…

RT @endpts: Breaking: Trump administration reveals new details on how it plans to execute "most favored nation" drug price targets. https:/…

RFK Jr. quietly adopted new chikungunya vaccine recommendations that incorporate Bavarian Nordic’s shot, while guidance from CDC advisors on the RSV vaccine remains in limbo. With @maxonwifi https://t.co/oD1oDgAcBm

RT @ArmstrongDrew: 📣We're two days out from the @FT x @endpts healthcare and biopharma summit in NYC, and OH MAN do we have a hell of a lin…

The White House plans to force down prices of drugs sold in the US by threatening to tie costs to rates paid by other countries, a directive that could have huge impacts but is almost certain to be broadly challenged in courts. @maxonwifi https://t.co/dsAuxxyi2O

AstraZeneca lost its challenge to Medicare drug price negotiations in the first appeals court ruling on the merits of the Biden-era program https://t.co/HkdsaeUDtw

RT @endpts: 🎙️Today at 11 a.m. ET, we're going live with Post Hoc to unpack Vinay Prasad’s move to lead FDA's Center for Biologics Evaluati…

Today I went to the grand opening of @AstraZeneca ’s new, $300M cell therapy manufacturing facility in Rockville, MD. The company plans to begin patient-batch manufacturing there early next year. https://t.co/oVPMj6Lrqg

RT @maxonwifi: Don't get me wrong, I like writing, but I'm really a professional yapper. And tomorrow is showtime with the first @endpts Po…

RT @endpts: 🎙️Let's talk tariffs! Tomorrow, we're going to bring our newsroom direct to you at 12 p.m. ET for Post-Hoc Live, talking about…